دورية أكاديمية

2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome

التفاصيل البيبلوغرافية
العنوان: 2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome
المؤلفون: Yeon-Ji Kim, Han-Hae Kim, Chul-Soo Shin, Jong-Won Yoon, Seon-Min Jeon, Young-Ha Song, Kwang-Youn Kim, Kyungho Kim
المصدر: Nutrients, Vol 15, Iss 8, p 1845 (2023)
بيانات النشر: MDPI AG, 2023.
سنة النشر: 2023
المجموعة: LCC:Nutrition. Foods and food supply
مصطلحات موضوعية: 2′-fucosyllactose, 3-fucosyllactose, inflammation, tight junction, ulcerative colitis, Nutrition. Foods and food supply, TX341-641
الوصف: Ulcerative colitis is an inflammatory bowel disease (IBD) with relapsing and remitting patterns, and it is caused by varied factors, such as the intestinal inflammation extent and duration. We examined the preventative effects of human milk oligosaccharides (HMOs) on epithelial barrier integrity and intestinal inflammation in an interleukin (IL)-6-induced cell model and dextran sodium sulfate (DSS)-induced acute mouse colitis model. HMOs including 2′-fucosyllactose (FL) and 3-FL and positive controls including fructooligosaccharide (FOS) and 5-acetylsalicylic acid (5-ASA) were orally administrated once per day to C57BL/6J mice with colitis induced by 5% DSS in the administered drinking water. 2′-FL and 3-FL did not affect the cell viability in Caco-2 cells. Meanwhile, these agents reversed IL-6-reduced intestinal barrier function in Caco-2 cells. Furthermore, 2′-FL and 3-FL reversed the body weight loss and the remarkably short colon lengths in DSS-induced acute colitis mice. Moreover, 2′-FL and 3-FL obviously protected the decreasing expression of zonula occluden-1 and occludin in colon tissue relative to the findings in the DSS-treated control group. 2′-FL and 3-FL significantly reduced IL-6 and tumor necrosis factor-α levels in serum relative to the control findings. The summary of these results shows that HMOs prevent colitis mainly by enhancing intestinal barrier function and advancing anti-inflammatory responses. Therefore, HMOs might suppress inflammatory responses and represent candidate treatments for IBD that protect intestinal integrity.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2072-6643
Relation: https://www.mdpi.com/2072-6643/15/8/1845; https://doaj.org/toc/2072-6643
DOI: 10.3390/nu15081845
URL الوصول: https://doaj.org/article/a2187367003645fca138a2f1619be442
رقم الأكسشن: edsdoj.2187367003645fca138a2f1619be442
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20726643
DOI:10.3390/nu15081845